November 23, 2005Open Access
ACNP Task Force Report on SSRIs and Suicidal Behavior in Youth
Key Points
Key points are not available for this paper at this time.
Abstract
This Task Force report by the American College of Neuropsychopharmacology evaluates the safety and efficacy of selective serotonin reuptake inhibitor (SSRIs) antidepressants for depressed youth under 18 years. The report was undertaken after regulatory agencies in the United States and United Kingdom raised concerns in 2003 about the possibility that treatment of depression in children and adolescents with SSRIs may increase the risk of suicidal thinking or suicide attempts.